NERV FY 2019 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$162,000

Operating Income

-$76M

Net Income

-$72M

EPS (Diluted)

$-14.80

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$77M

Total Liabilities

$50M

Stockholders' Equity

$28M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$162,000	-$17,467	-827.5%
Operating Income	-$76M	-$52M	-46.7%
Net Income	-$72M	-$50M	-43.9%